MSOS: Trump's Green Light - Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)

MSOS is upgraded to Buy ahead of US cannabis rescheduling catalysts—Schedule III could end 280E taxes, boost MSO profits, and ...

Medical marijuana reclassified as less dangerous drug. Pot stocks go up in smoke

The Trump administration also announced the beginning of an expedited administrative hearing process to consider the ...

1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It?

Tilray is showing signs of improvement. But a 40% jump over the next 12 months might be a stretch.

Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?

Amplify Alternative Harvest ETF (NYSEMKT: MJ) targets the broader global cannabis market -- with a heavy weighting on ...

Pot stocks rise as DOJ reschedules marijuana as a less-dangerous drug

Cannabis stocks jump as the U.S. Department of Justice reschedules state-licensed medical marijuana as a less dangerous drug.

From $500 to $1: Is Canopy Growth a Dead Stock Walking or the Ultimate Turnaround Play?

Err on the side of caution with this falling knife.

Trump administration moves to reclassify cannabis in major shift that could expand research

Trump administration to reclassify marijuana as Schedule III, easing research barriers but not legalizing the drug or ...

The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off

Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved ...